Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dengue Vaccines”

144 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 144 results

Testing effectiveness (Phase 2)Study completedNCT00730288
What this trial is testing

Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects

Who this might be right for
DengueDengue FeverDengue Hemorrhagic Fever+1 more
Sanofi 35
Not applicableLooking for participantsNCT07358910
What this trial is testing

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Who this might be right for
DengueChikungunyaZika Virus Infection+55 more
Institut Pasteur du Cambodge 10,000
Early research (Phase 1)Study completedNCT02887482
What this trial is testing

GLS-5700 in Dengue Virus Seropositive Adults

Who this might be right for
HealthyZika
GeneOne Life Science, Inc. 160
Early research (Phase 1)Study completedNCT00920517
What this trial is testing

Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine

Who this might be right for
Dengue Fever
National Institute of Allergy and Infectious Diseases (NIAID) 25
Early research (Phase 1)Study completedNCT04786457
What this trial is testing

ADVP005; Dengue CVD 12000 - Dengue-1-Virus Live Virus Human Challenge (DENV-1-LVHC)

Who this might be right for
Dengue
University of Maryland, Baltimore 10
Testing effectiveness (Phase 2)Study completedNCT02193087
What this trial is testing

Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)

Who this might be right for
Dengue Fever
Takeda 1,002
Early research (Phase 1)Study completedNCT00089908
What this trial is testing

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults

Who this might be right for
Dengue Fever
National Institute of Allergy and Infectious Diseases (NIAID) 28
Testing effectiveness (Phase 2)Study completedNCT02628444
What this trial is testing

Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 1,050
Testing effectiveness (Phase 2)Study completedNCT02948829
What this trial is testing

Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children

Who this might be right for
Healthy Volunteers
Takeda 200
Large-scale testing (Phase 3)Study completedNCT03341637
What this trial is testing

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) in Adolescents in Non-Endemic Area(s)

Who this might be right for
Dengue
Takeda 400
Early research (Phase 1)Study completedNCT01110551
What this trial is testing

Tetravalent Chimeric Dengue Vaccine Trial

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 72
Early research (Phase 1)Study completedNCT02186626
What this trial is testing

Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age

Who this might be right for
West Nile Virus
National Institute of Allergy and Infectious Diseases (NIAID) 28
Not applicableActive Not RecruitingNCT07158190
What this trial is testing

Evaluation of T-cell Responses After Vaccination With the Attenuated Tetravalent Dengue Vaccine (Takeda).

Who this might be right for
Dengue
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 30
Early research (Phase 1)Study completedNCT00919178
What this trial is testing

Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus

Who this might be right for
Dengue Shock SyndromeDengue Hemorrhagic Fever
National Institute of Allergy and Infectious Diseases (NIAID) 70
Not applicableStudy completedNCT03960385
What this trial is testing

Assessing the Effectiveness of Sanofi Pasteur's Dengue Vaccine (Dengvaxia) Against Hospitalization and Symptomatic Infection in the State of Parana - Brazil

Who this might be right for
Dengue
Albert B. Sabin Vaccine Institute 1,854
Early research (Phase 1)Study completedNCT02873260
What this trial is testing

Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 48
Not applicableActive Not RecruitingNCT07501793
What this trial is testing

Demographic Characteristics of TAK-003 Dengue Vaccine Recipients in Vietnam

Who this might be right for
Dengue
Tam Anh Research Institute 800,000
Large-scale testing (Phase 3)Study completedNCT03771963
What this trial is testing

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) at the End of Shelf Life in Healthy Adults

Who this might be right for
Dengue Fever
Takeda 200
Early research (Phase 1)Study completedNCT02809443
What this trial is testing

GLS-5700 in Dengue Virus-Naïve Adults

Who this might be right for
Healthy
GeneOne Life Science, Inc. 40
Not applicableUnknownNCT05213364
What this trial is testing

Dengue Vaccine Hesitancy and Acceptance in Endemic Regions of Argentina: Impact of Communication Strategies

Who this might be right for
Dengue
Fundacion GESICA 1,500
Next Page